The Oxytocin Landscape

The science of oxytocin (OT) and its potential therapeutic benefit in PWS continues to be a high profile, priority research area for the PWS community and for FPWR. Several studies have taken place investigating oxytocin as a therapeutic for...

Special News and Announcements – July 15, 2015

Welcome Nathalie Kayadjanian to the FPWR Team! Nathalie Kayadjanian, Ph.D is an expert in translational biomedical research. A neuroscientist by training, she has extensive research and development (R&D) experience in academia, biotech, and the pharmaceutical industry in Europe and the...

Special News and Announcements – July 8, 2015

What is the key to overcoming bottlenecks in clinical trials? This month FPWR is holding an important workshop on Overcoming Bottlenecks in Clinical Trials of Investigational Medicinal Products for Hyperphagia in Prader-Willi Syndrome. We have gathered key stakeholders from academia, pharmaceutical industry,...

Clinical Trials Alert Summer 2015

  JUNE 2015. There are several new and ongoing opportunities for PWS families to participate in clinical studies. For more information on the opportunities below, as well as others, please visit https://www.fpwr.org/category/clinical-trials or clinicaltrials.gov. We encourage members of the PWS community to...